Product Pathways - DNA Damage
DNA-PK Antibody #4602
|4602S||100 µl (10 western blots)||---||In Stock||---|
|4602P||40 µl (4 western blots)||---||In Stock||---|
|4602||carrier free and custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
DNA-PK Antibody detects endogenous levels of DNA-PK protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to amino acids near the carboxy-terminus of human DNA-PKcs. Antibodies are purified by protein A and peptide affinity chromatography.
DNA-dependent protein kinase (DNA-PK) is an important factor in the repair of double-stranded breaks in DNA. Cells lacking DNA-PK or in which DNA-PK is inhibited fail to show proper nonhomologous end-joining (NHEJ) (1-7). DNA-PK is composed of two DNA-binding subunits (Ku70 and Ku86) and one 450 kDa catalytic subunit (DNA-PKcs) (8). It is thought that a heterodimer of Ku70 and Ku86 binds to double-stranded DNA broken ends before DNA-PKcs binds and is activated (1,9). Activated DNA-PKcs is a serine/threonine kinase that has been shown to phosphorylate a number of proteins in vitro, including p53, transcription factors, RNA polymerase, and Ku70/Ku86 (10,11). DNA-PKcs autophosphorylation at multiple sites, including Thr2609 and Ser2056, results in an inactivation of DNA-PK kinase activity and NHEJ ability (12,13). It has been demonstrated, however, that DNA-PK preferentially phosphorylates substrates before it autophosphorylates, suggesting that DNA-PK autophosphorylation may play a role in disassembly of the DNA repair machinery (14,15). Autophosphorylation at Thr2609 has also been shown to be required for DNA-PK-mediated double strand break repair, and phosphorylated DNA-PK co-localizes with H2A.X and 53BP1 at sites of DNA damage (16). Phosphorylation at Ser2056 occurs in response to double-stranded DNA breaks and ATM activation (17).
- Gottlieb, T.M. and Jackson, S.P. (1993) Cell 72, 131-42.
- Hartley, K. O. et al. (1995) Cell 82, 840-856.
- Rosenzweig, K.E. et al. (1997) Clin Cancer Res 3, 1149-56.
- Jackson, S.P. and Jeggo, P.A. (1995) Trends Biochem Sci 20, 412-5.
- Roth, D.B. et al. (1995) Curr Biol 5, 496-9.
- Baumann, P. and West, S.C. (1998) Proc Natl Acad Sci U S A 95, 14066-70.
- Chen, S. et al. (2001) J Biol Chem 276, 24323-30.
- Jeggo, P.A. (1997) Mutat Res 384, 1-14.
- Suwa, A. et al. (1994) Proc Natl Acad Sci U S A 91, 6904-8.
- Anderson, C.W. and Lees-Miller, S.P. (1992) Crit Rev Eukaryot Gene Expr 2, 283-314.
- Kuhn, A. et al. (1995) Genes Dev 9, 193-203.
- Chan, D.W. and Lees-Miller, S.P. (1996) J Biol Chem 271, 8936-41.
- Douglas, P. et al. (2002) Biochem. J. 368, 243-251.
- Lees-Miller, S.P. et al. (1992) Mol Cell Biol 12, 5041-9.
- Jackson, S.P. et al. (1990) Cell 63, 155-65.
- Chan, D.W. et al. (2002) Genes Dev 16, 2333-8.
- Yajima, H. et al. (2009) J Mol Biol 385, 800-10.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 2851 Phospho-(Ser/Thr) ATM/ATR Substrate Antibody
- 4526 Phospho-ATM (Ser1981) (10H11.E12) Mouse mAb
- 4215 Phospho-DNA-PK (Ser2056) Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.